mend, a New York-based life sciences and digital health company, raised $15M in Series A funding.
The round was led by S2G Ventures.
The company intends to use the funds to execute existing provider contracts, scale its program nationwide, and accelerate its research and development to further enhance its technology platform, nutrapharma, food as medicine products, and clinical services.
Led by CEO Eziah Syed, Mend is a life sciences company that provides nutrapharma products, which are clinically proven, science backed, and recognized by the medical community to be effective in accelerating repair, recovery, and improving key risk factors contributing to chronic conditions. They are integrated with one-on-one coaching powered by AI. The platform works with hospitals and universities on developing evidence-based programs to enhance patient outcomes.
In 2022, mend launched a line of targeted, evidence-based nutrapharma products integrated into the mend digital behavioral health coaching platform, Upgraid™ by mend, which extends the care delivery model beyond the hospital setting to further recovery in the home and support patients into healthier habits that last. Upgraid™ by mend is a ‘human-first’ SMS based and AI-enabled platform that helps hospital systems to extend recovery beyond the hospital, elevating the level of care and alleviating the burden on providers.